NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	12/02/2015
Target sample size	200
Countries of recruitment	Japan,Asia except Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Avelumab INN of investigational material : avelumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : -

Outcome(s)

Primary Outcome	safety efficacy Number of Participants With Confirmed Best Overall Response (BOR) as Per Response Evaluation Criteria in Solid Tumors Version (RECIST) 1.1
Secondary Outcome	safety efficacy Duration of Response According to Response Evaluation Criteria in Solid Tumors Version (RECIST) 1.1

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria